No significant differences were observed in most clinical and biochemical parameters between non-obese and obese PCOS women after FDR Benjamini–Hochberg adjustment (Table 1), except for adiponectin levels, which were significantly decreased in the obese group (FDR-adjusted p = 0.030) (Table 1). The gene discussed is ADIPOQ; the disease is polycystic ovary syndrome.